Studies Proving Generic Drugs Can Fight COVID Are Being Suppressed
December 20th, 2021Via: The Federalist:
To broaden our knowledge of COVID-19 and identify the best ways to treat and prevent it, doctors should be able to use every possible safe means at their disposal to help patients. Unfortunately, that is impossible in our current political climate.
Since the summer of 2020, U.S. public health agencies have continually shut down the use or even discussion of generic treatments that are minimally profitable. The National Institutes of Health (NIH) funded 20 large research studies of patented pharmaceutical industry drugs before only recently (and slowly) agreeing to study repurposed generic medicines.
The Food and Drug Administration and the Centers for Disease Control have recommended next to none. Instead, the Biden administration has thrown its political weight almost solely behind mass vaccinations, and hospitals and pharmacies have dogmatically followed suit. But this approach is proving insufficient to arrest COVID-19.
